ストックスクリーナーアプリを入手
34.90
0.61%
-0.19
アフターアワーズ：
34.89
-0.010
-0.03%
前日終値:
$35.09
開ける：
$34.9
24時間の取引高:
1.07M
Relative Volume:
0.53
時価総額：
$7.20B
収益：
$2.09B
当期純損益:
$424.88M
株価収益率:
17.08
EPS:
2.0439
ネットキャッシュフロー:
$447.20M
1週間 パフォーマンス:
+4.76%
1か月 パフォーマンス:
-13.03%
6か月 パフォーマンス:
-25.54%
1年 パフォーマンス:
-17.59%
1日の値動き範囲:
$34.42
$35.08
1週間の範囲:
$32.91
$35.12
52週間の値動き範囲:
$32.53
$57.81
Qiagen Nv Stock (QGEN) Company Profile
Compare QGEN vs TMO, DHR, IDXX, WAT, A
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
34.91 | 7.24B | 2.09B | 424.88M | 447.20M | 2.0439 |
TMO
Thermo Fisher Scientific Inc
|
449.26 | 167.89B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
173.25 | 121.11B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
552.77 | 43.67B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
340.79 | 33.51B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
114.75 | 32.15B | 7.07B | 1.29B | 993.00M | 4.5355 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-14 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2026-03-13 | アップグレード | Deutsche Bank | Hold → Buy |
| 2026-01-22 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-06-24 | 開始されました | Barclays | Overweight |
| 2025-04-04 | ダウングレード | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | アップグレード | Jefferies | Hold → Buy |
| 2024-10-17 | ダウングレード | HSBC Securities | Buy → Hold |
| 2024-06-27 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-12-07 | アップグレード | Goldman | Neutral → Buy |
| 2023-09-12 | 開始されました | Robert W. Baird | Outperform |
| 2023-05-23 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-01-18 | アップグレード | DZ Bank | Hold → Buy |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-10-14 | 開始されました | Redburn | Buy |
| 2021-07-14 | ダウングレード | Kepler | Buy → Hold |
| 2021-06-03 | 開始されました | Goldman | Neutral |
| 2020-10-06 | 再開されました | BofA Securities | Buy |
| 2020-09-28 | アップグレード | Kepler | Hold → Buy |
| 2020-08-24 | アップグレード | Citigroup | Neutral → Buy |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-08-17 | アップグレード | Berenberg | Hold → Buy |
| 2020-08-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-08-14 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | ダウングレード | Berenberg | Buy → Hold |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-12-26 | 再開されました | BofA/Merrill | Underperform |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-11-14 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-11-14 | アップグレード | JP Morgan | Underweight → Overweight |
| 2019-11-14 | アップグレード | Kepler | Reduce → Hold |
| 2019-10-17 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | ダウングレード | Kepler | Hold → Reduce |
| 2019-10-08 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-10-08 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2019-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
すべてを表示
Qiagen Nv (QGEN) 最新ニュース
QIAGEN Stock Up on the Launch of AI-Powered Workflow Agent Platform - Zacks Investment Research
Qiagen N.V. stock (NL0012169213): Outlook raised after Q1 2026 update and new AI assistant launch - AD HOC NEWS
QIAGEN Discloses Million-Dollar Insider Share Purchase by Supervisory Board Member Trust - TipRanks
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Managers' transactions announcement according to article 19 MAR - TradingView
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows - BioSpace
Qiagen stock (NL0012169213): Q1 update and share-price backdrop - AD HOC NEWS
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflo - PharmiWeb.com
Qiagen launches AI assistant for laboratory research - Investing.com
Qiagen launches AI assistant for laboratory research By Investing.com - Investing.com Australia
New QIAGEN AI lab assistant is designed to speed experiment planning - Stock Titan
QIAGEN launches AI assistant for laboratory workflow support - StreetInsider
Qiagen N.V. stock (NL0012169213): Diagnostics group lifts 2026 outlook after first?quarter earnings - AD HOC NEWS
Qiagen N.V. stock (NL0012169213): steady earnings backdrop as shares lag 2026 highs - AD HOC NEWS
Qiagen (QGEN) Securities Fraud InvestigationLevi & Korsinsky - PR Newswire
QIAGEN and NVIDIA partner on AI drug discovery - Yahoo Finance
Qiagen stock (NL0012169213): Q1 update keeps diagnostics and life-science demand in focus - AD HOC NEWS
QIAGEN partners with NVIDIA on AI drug discovery platform By Investing.com - Investing.com Nigeria
QGEN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Qiagen N.V. - Business Wire
QIAGEN partners with NVIDIA to integrate AI into drug discovery platform - StreetInsider
Qiagen's Digital Insights Business to Integrate Nvidia's BioNeMo Platform - marketscreener.com
QIAGEN partners with NVIDIA on AI drug discovery platform - Investing.com
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA - Yahoo Finance
Qiagen discloses AFM notification on 2.99% Bank of America stake - TipRanks
Qiagen N.V. stock (NL0012169213): earnings outlook and molecular diagnostics focus - AD HOC NEWS
Stifel Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $36 - Moomoo
Citigroup downgrades Qiagen NV (QGEN) - MSN
Qiagen N.V. stock (NL0012169213): diagnostics specialist updates investors after Q1 results - AD HOC NEWS
QGEN Maintained by Stifel -- Price Target Lowered to $36 - GuruFocus
Bank of America Discloses 2.98% Stake in Qiagen via AFM Filing - TipRanks
Qiagen stock (NL0012169213): New strategic tie-up puts diagnostics in focus - AD HOC NEWS
Qiagen N.V. (QGEN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Release according to Article 40, Section 1 of the WpHG - TradingView
Stifel cuts Qiagen stock price target to $36 on weaker outlook By Investing.com - Investing.com Australia
Qiagen stock (NL0012169213): QIAGEN’s U.S. diagnostics exposure stays in focus - AD HOC NEWS
Stifel cuts Qiagen stock price target to $36 on weaker outlook - Investing.com Australia
Qiagen NV (QGEN) PT Lowered to $36 at Stifel on 'Lower Growth Outlook' - StreetInsider
Stifel Maintains Qiagen NV(QGEN.US) With Hold Rating, Cuts Target Price to $36 - Moomoo
Qiagen N.V. (QGEN) Investor Outlook: A 32.87% Upside Potential in the Diagnostics & Research Sector - DirectorsTalk Interviews
QGEN Stock Price, Quote & Chart | QIAGEN N.V. (NYSE:QGEN) - ChartMill
Bronstein, Gewirtz & Grossman, LLC Is Investigating Qiagen N.V. (QGEN) And Encourages Investors to Connect - ACCESS Newswire
Qiagen N.V. stock (NL0012169213): earnings momentum and diagnostics demand keep investors watching - AD HOC NEWS
QIAGEN NV cuts FY outlook despite in-line prelim Q1 EPS - MSN
Qiagen N.V. stock (NL0012169213): Q1 2026 earnings and outlook keep diagnostics specialist in focus - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Encourages Qiagen N.V. (QGEN) - The National Law Review
Law firm investigates Qiagen over potential securities law violations after stock drops 11%. - Pluang
QIAGEN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Qiagen N.V. on ... - Herald and News
QIAGEN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
QIAGEN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Qiagen N.V. on Behalf of Qiagen Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Qiagen N.V. stock (NL0012169213): Dividend announced as 2026 guidance cut weighs on sentiment - AD HOC NEWS
Qiagen NV (QGEN) price target decreased by 13.91% to 46.28 - MSN
Qiagen Nv (QGEN) 財務データ
収益
当期純利益
現金流量
EPS
0.02%
2.11%
大文字化:
|
ボリューム (24 時間):